CLINICAL-FEATURES AND OUTCOME OF 80 PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
GABRIELLI, A [1 ]
CORVETTA, A [1 ]
MONTRONI, M [1 ]
RICCIATTI, AM [1 ]
NITTI, C [1 ]
DANIELI, MG [1 ]
DANIELI, G [1 ]
机构
[1] UNIV ANCONA,IST CLIN MED,I-60100 ANCONA,ITALY
来源
JOURNAL OF IMMUNOLOGICAL RESEARCH | 1991年 / 3卷 / 04期
关键词
MORBIDITY; MORTALITY; SYSTEMIC LUPUS ERYTHEMATOSUS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The spectrum of organ involvement and outcome of 80 patients with Systemic Lupus Erythematosus (SLE) have been assessed in a retrospective study. Joint manifestations and constitutional symptoms were the most common features. Nephritis was present in 16 patients at disease onset and developed in further 21 during the course of their disease. Patients with late-onset SLE (after age 50; 33.3%) had a lower incidence of renal disease similar to that found in patients younger than 20 years (26.3%). The mean interval from onset of first symptoms to diagnosis was shorter in patients evaluated from 1984 to 1989: 7.2 months versus 24.9 months of the patients first seen in the previous six years. Eight deaths occurred (10%) and lupus-related organ or system involvement (mainly CNS and active nephritis) were the most frequent primary causes of death. Two of the patients who died of cerebrovascular disease had high anticardiolipin antibodies and in a third the level was borderline. This finding implies that antiphospholipid immunity may be an important contributing cause of death and underscores the urgency of an appropriate treatment of this abnormality.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 50 条
  • [21] ASPLENISM AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    LIOTE, F
    ANGLE, J
    GILMORE, N
    OSTERLAND, CK
    CLINICAL RHEUMATOLOGY, 1995, 14 (02) : 220 - 223
  • [22] NARCOLEPSY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    PABLOS, JL
    DELRINCON, E
    FRANCISCO, F
    MATEO, I
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (02) : 375 - 376
  • [23] SYSTEMIC LUPUS-ERYTHEMATOSUS AND PREGNANCY
    DERKSEN, RHWM
    RHEUMATOLOGY INTERNATIONAL, 1991, 11 (03) : 121 - 125
  • [24] METHOTREXATE IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    LEBLANC, BAEW
    DAGENAIS, P
    UROWITZ, MB
    GLADMAN, DD
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (05) : 836 - 838
  • [25] POSTURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    GIACOMINI, P
    ZOLI, A
    BRUNO, E
    DIGIROLAMO, S
    CARICCHIO, R
    ALTOMONTE, L
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 (03) : 357 - 360
  • [26] FACETIOUS SYSTEMIC LUPUS-ERYTHEMATOSUS
    FONSECA, E
    RUBIO, G
    LUPUS, 1993, 2 (03) : 195 - 197
  • [27] PREGNANCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    JULKUNEN, H
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1994, 23 (01) : 54 - 54
  • [28] SYSTEMIC LUPUS-ERYTHEMATOSUS AND PREGNANCY
    ROTHER, E
    LANG, B
    PETER, HH
    IMMUNITAT UND INFEKTION, 1992, 20 (04): : 113 - 116
  • [29] Clinical Profile of Patients with Systemic Lupus Erythematosus
    Paudyal, B. P.
    Gyawalee, M.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (03) : 111 - 117
  • [30] PREGNANCY AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    SAMTLEBEN, W
    NEUMEIER, D
    GURLAND, HJ
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1993, 22 (06) : 223 - 231